Amit Barua, Joseph Hubble, Kathryn Yoo, Michael Lacassagne, John P. Areno, Louis Trachtman and Juzar Ali*
Department of Health, Office of Public Health, Tuberculosis Control, Louisiana, USA
*Corresponding Author: Juzar Ali, LSUHSC, & Office of Public Health, Tuberculosis Control, Louisiana, USA.
Received: June 09, 2021; Published: August 16, 2021
Citation: Michael Lacassagne and Juzar Ali. "Recurrent Pulmonary Tuberculosis in Low Prevalence Settings: Case Report from Louisiana". Acta Scientific Microbiology 5.9 (2021): 71-74.
Recurrence of Pulmonary tuberculosis (TB) after successful completion of supervised treatment may be due to relapse or reinfection. Recurrence is common with an incidence rate of 2.26 per 100 person years over a mean follow up of 2.3 years. However, it is uncommon for an immunocompetent individual to experience multiple episodes of recurrences. We describe a 67yo, Human Immunodeficiency Virus (HIV) seronegative man, seen in the public health system in Louisiana, USA with multiple relapses of TB due to drug susceptible MTB despite successful completion of guideline based direct observed treatment regimen in each episode. This case report highlights the need for increased awareness and recognition of risk factors contributing to the recurrence of TB even in countries with low prevalence of TB. Better understanding of the importance of drug penetration and action on varying mycobacterial populations within diseased lung tissue would also aid clinicians in the management of these relapses.
Keywords: Recurrent Tuberculosis; Pulmonary Tuberculosis; Relapse; Low TB Prevalence Area
Copyright: © 2021 Amit Barua., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.